EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Connectivity- and frequency-individualized accelerated intermittent theta burst stimulation in treatment-resistant depression: A randomized controlled trial

Lawrence G Appelbaum, Louise A Stolz, Yinming Sun, Jordan N Kohn, Mohsen Poorganji, Itay Hadas, Bianca Bacio, Katie Rodriguez, Emma C Boyd, Eva Wiener, Xia Li, Paul B Fitzgerald und 3 weitere

Journal of Affective Disorders · 2026

DOI: 10.1016/j.jad.2026.122515 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2026. Verfasst von Lawrence G Appelbaum und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of California San Diego, La Jolla, CA, USA. Electronic address: greg@health.ucsd.edu. Hauptthemen laut MEDLINE: Transcranial Magnetic Stimulation, Depressive Disorder, Treatment-Resistant, Theta Rhythm. Die Arbeit nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accelerated intermittent theta burst stimulation (aiTBS) is an effective neuromodulatory intervention for treatment resistant depression (TRD). aiTBS delivers repetitive transcranial magnetic stimulation sessions over a compressed timeframe and can be individualized to specific locations using resting-state functional magnetic resonance imaging (rs-fMRI) to target pathological cortical networks or individualized in time using electroencephalography (EEG) to determine optimal participant-specific stimulation frequencies. In this randomized, placebo-controlled trial, we tested these forms of personalization against sham stimulation. Fifty-one patients with TRD were randomized to one of three arms; 43 completed the protocol per pre-specified criteria and assigned to one of three arms: (1) fMRI-connectivity-individualized aiTBS; (2) frequency- and connectivity-individualized aiTBS; or (3) sham aiTBS. Participants received 10 aiTBS sessions per day for five consecutive days with clinical assessments at baseline, and 1 and 4 weeks post-treatment. The primary outcome was change in depression severity on the Montgomery-Åsberg Depression Rating Scale from baseline to 1 week post-treatment. Anhedonia severity measured with the Dimensional Anhedonia Rating Scale was a secondary outcome. No significant differences were observed between active and sham arms on primary MADRS or secondary DARS endpoints for either the intent-to-treat or per-protocol sample. Remission and response rates also did not differ between arms. aiTBS individualized using either rs-fMRI or EEG and rs-fMRI failed to yield significant antidepressant benefits over sham stimulation, with relatively muted overall therapeutic benefits, underscoring the need for further clinical trials evaluating the efficacy of personalized aiTBS in TRD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcranial Magnetic StimulationDepressive Disorder, Treatment-ResistantTheta RhythmHumansMagnetic Resonance ImagingFemaleAdultMaleMiddle AgedElectroencephalographyTreatment OutcomeAnhedonia

Stichwörter der Autor:innen

Accelerated intermittent theta burst stimulationClinical trialIndividualized therapyPersonalizationRepetitive transcranial magnetic stimulationTreatment resistant depression

Autor:innen und Institutionen

  • Department of Psychiatry, University of California San Diego, La Jolla, CA, USA. Electronic address: greg@health.ucsd.edu.
  • Department of Psychiatry, University of California San Diego, La Jolla, CA, USA.
  • Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, CA, USA.
  • School of Medicine and Psychology, Australian National University, Canberra, ACT, Australia.

Zitieren

APA

Appelbaum, L. G., Stolz, L. A., Sun, Y., Kohn, J. N., Poorganji, M., Hadas, I., Bacio, B., Rodriguez, K., Boyd, E. C., Wiener, E., Li, X., Fitzgerald, P. B., Miron, J. P., Weissman, C. R., & Daskalakis, Z. J. (2026). Connectivity- and frequency-individualized accelerated intermittent theta burst stimulation in treatment-resistant depression: A randomized controlled trial. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2026.122515

Vancouver

Appelbaum LG, Stolz LA, Sun Y, Kohn JN, Poorganji M, Hadas I, et al. Connectivity- and frequency-individualized accelerated intermittent theta burst stimulation in treatment-resistant depression: A randomized controlled trial. Journal of Affective Disorders. 2026. doi:10.1016/j.jad.2026.122515

BibTeX
@article{Appelbaum2026,
  author = {Appelbaum, Lawrence G and Stolz, Louise A and Sun, Yinming and Kohn, Jordan N and Poorganji, Mohsen and Hadas, Itay and Bacio, Bianca and Rodriguez, Katie and Boyd, Emma C and Wiener, Eva and Li, Xia and Fitzgerald, Paul B and Miron, Jean-Philippe and Weissman, Cory R and Daskalakis, Zafiris J},
  title = {Connectivity- and frequency-individualized accelerated intermittent theta burst stimulation in treatment-resistant depression: A randomized controlled trial},
  journal = {Journal of Affective Disorders},
  year = {2026},
  doi = {10.1016/j.jad.2026.122515}
}
Kostenlos starten →